ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Tributylphosphine → 4-(4-Chloro-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-3-ylmethoxy)quinazoline

HRID 2182542
印刷

反応式

HRID 2182542 の反応式
[Cl:1][C:2]1[CH:21]=[CH:20][C:5]([NH:6][C:7]2[C:16]3[C:11](=[CH:12][C:13]([OH:19])=[C:14]([O:17][CH3:18])[CH:15]=3)[N:10]=[CH:9][N:8]=2)=[C:4]([F:22])[CH:3]=1.[CH3:23][N:24]1[CH2:29][CH2:28][CH2:27][CH:26]([CH2:30]O)[CH2:25]1.C(P(CCCC)CCCC)CCC>C(Cl)Cl.CCOCC>[Cl:1][C:2]1[CH:21]=[CH:20][C:5]([NH:6][C:7]2[C:16]3[C:11](=[CH:12][C:13]([O:19][CH2:30][CH:26]4[CH2:27][CH2:28][CH2:29][N:24]([CH3:23])[CH2:25]4)=[C:14]([O:17][CH3:18])[CH:15]=3)[N:10]=[CH:9][N:8]=2)=[C:4]([F:22])[CH:3]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 3

HCID 13831TributylphosphineHCID 97998(1-Methyl-3-piperidyl)methanolHCID 1355137204-(4-Chloro-2-fluorophenylamino)-7-hydroxy-6-methoxyquinazoline

生成物 1

HCID 224781994-(4-Chloro-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-3-ylmethoxy)quinazoline収率 33%

試薬・触媒・溶媒 2

HCID 3283Diethyl Ether溶媒
HCID 6344
Dichloromethane
溶媒

実験手順

1,1′-Azodicarbonyl)dipiperidine (560 mg, 2.2 mmol) was added in portions to a mixture of 4-(4-chloro-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline (240 mg, 0.75 mmol), (prepared as described for the starting material in Example 2), 1-methyl-3-piperidinemethanol (115 mg, 0.89 mmol) and tributylphosphine (440 mg, 2.2 mmol) in methylene chloride (10 ml). The mixture was stirred for 18 hours, diluted with ether and the resulting precipitate was removed by filtration. The volatiles were removed from the filtrate by evaporation, and the residue was dissolved in acetone and ethereal hydrogen chloride 1.5 ml of a 1M solution, 1.5 mmol) was added. The precipitated product was collected by filtration and purified by column chromatography eluting with methylene chloride/methanol/aqueous ammonia (75/8/1). The purified solid product was triturated with ether collected by filtration and dried to give 4-(4-chloro-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-3-ylmethoxy)quinazoline (105 mg, 33%).

後処理

  1. custom(prepared
  2. customthe resulting precipitate was removed by filtration
  3. customThe volatiles were removed from the filtrate by evaporation
  4. dissolutionthe residue was dissolved in acetone
  5. additionethereal hydrogen chloride 1.5 ml of a 1M solution, 1.5 mmol) was added
  6. filtrationThe precipitated product was collected by filtration
  7. custompurified by column chromatography
  8. washeluting with methylene chloride/methanol/aqueous ammonia (75/8/1)
  9. customThe purified solid product was triturated with ether
  10. filtrationcollected by filtration
  11. customdried

出典と根拠

ORDレコード
ord-cc3c8cb74eee41008ad441efa4195327
出典データセット
uspto-grants-2005_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06897210B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート